Assessment of Response to Anti-angiogenic Targeted Therapy in Pulmonary Metastatic Renal Cell Carcinoma R2 value as a Predictive Biomarker

This study was to evaluate the usefulness of magnetic resonance(MR) R2* mapping in assessing response of treatment in patients with pulmonary metastatic renal cell carcinoma receiving anti-angiogenic targeted therapy.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.